Leading Justice is a full-service marketing company working with law firms on a cash buy basis to sign up fully-qualified, fraud-free Lipitor cases. Here at Leading Justice, we can custom tailor your law firm’s Lipitor advertising needs and help you sign up cases via internal cash buys. Our clients simply pay an agency fee to cover the cost of Lipitor advertising, plus a fee for each case we sign, and any data we generate for your firm belongs to you. We also cross-qualify all of our contacts, which means any data we generate that doesn’t qualify for the target campaign is reviewed to determine whether it is eligible for another type of claim. By utilizing innovative approaches to target contacts specifically associated with Lipitor, Type 2 diabetes and other potential side effects, Leading Justice will increase your firm’s Lipitor case load. If you and your firm are interested in helping victims of side effects allegedly linked to the cholesterol drug Lipitor, our vast consumer reach and direct advertising strategies give you the competitive edge and confidence to allocate your full budget, with the knowledge that your money is being spent in the best way possible.
Every law firm we work with at Leading Justice plays an important role in how we categorize claims as qualified or not. While our experience working alongside plaintiff law firms allows us to recognize a great case when we see one, we will customize our Lipitor case intake specifications to the exact criteria you are seeking. So, if your firm has Lipitor qualifying case criteria you would like us to use, we will train our intake specialists to apply the criteria to each email and phone call they receive. By getting rid of the middle man, Leading Justice offers clients an opportunity for internal cash buys of Lipitor date with no chance of fraud.
Our Take on Potential Lipitor Side Effects
Millions of consumers have filled prescriptions for Lipitor, a cholesterol-lowering drug that mounting research suggests may put patients at risk of irreversible side effects, including Type 2 diabetes in women. According to a study conducted recently by the University of Massachusetts Medical School, of the 153,840 women taking Lipitor that were evaluated between 1993 and 2005, more than 10,200 developed Type 2 diabetes by the conclusion of the study. Not only is diabetes a disease that often requires ongoing medical care and medication, but it can also sometimes lead to hospitalization, surgery and even death. Findings like these create an opportunity for Lipitor patients to file suit against Pfizer for allegedly manufacturing and selling a defective medication to consumers, joining the many victims who are already seeking compensation from the drug company.